Completed PHASE2 INTERVENTIONAL 2-arm NCT01172522

Topical Treatment of Under Eye Dark Circles and Swelling

A Pilot Randomized Double Blind Study to Assess the Safety and Efficacy of 1% Ibuprofen/ 1%Fexofenadine Topical Cream for the Treatment of Dark Circles Under the Eyes

Sponsor: TKL Research, Inc.

Conditions Edema

Interventions Fexofenadine Placebo

Updated 8 times since 2017 Last updated: Feb 16, 2015 Started: Sep 30, 2010 Primary completion: Dec 31, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01172522, this PHASE2 trial focuses on Edema and remains completed. Sponsored by TKL Research, Inc., it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TKL Research, Inc.
The Connecticut Sinus Center, PC

Data source: The Connecticut Sinus Center, PC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paramus, United States